We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:JAZZ
​
​
logo

Jazz Pharmaceuticals (JAZZ)

Nasdaq • JAZZ • IE00B4Q5ZN47

234.66Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 21, 2026, ORTEX estimates 9.3% of free float is sold short, 7 days to cover, cost to borrow 0.45%.

Market Cap

15b USD | # 1232 in US

Volume

889.39k shares | 209.3m USD

Shares Outstanding

64.19m

Free Float Shares

97.00% | 62.26m

DB:J7Z|
XTRA:J7Z|
BOVESPA:J2AZ34|
BIT:1JAZZ

News

JAZZ key data

Jazz Pharmaceuticals (Nasdaq: JAZZ) has a market capitalization of $15.04B. Last close $234.66 (as of 2026-11-05); 52-week range $128.80 to $266.38. ORTEX data as of 2026-10-21: short interest is 9.26% of free float, 7 days to cover and the average cost to borrow is 0.45%.

  • JAZZ news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.